LENSAR, Inc.

LNSR Nasdaq SEC CIK 1320350
Follow Lensar Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $12.4M −2.6% vs same quarter last year
Net income −$4.7M −27.2% vs same quarter last year
EPS, diluted −$0.38 −22.6% vs same quarter last year
Operating cash flow −$866K +75.3% vs same quarter last year
Revenue by quarter
$14.8M
$12.3M
$12.3M
$12.8M
$14.3M
$11.7M
$14.7M
$12.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$50M−$25M$0$25M$50M$75MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$51.7M−$34.3M
FY24$46M−$31.4M
FY23$35.7M−$14.4M
FY22$29.4M−$19.9M
FY21$29.5M−$19.6M
FY20$22.8M−$19.8M
FY19$26.3M−$14.7M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2539.4%−47.6%−66.4%
FY2439.9%−23.2%−68.3%
FY2341%−34.2%−40.3%
FY2247.7%−68.5%−67.6%
FY2143.6%−66.6%−66.5%
FY2046%−81.2%−86.8%
FY1934.3%−48.3%−55.6%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$14.9M
FY24−$2.4M
FY23−$9.9M
FY22−$15M
FY21−$9.3M
FY20−$14.2M
FY19−$13M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Lensar
  • Healthcare median
−100%−75%−50%−25%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearLensarHealthcare median
FY25−66.4%−30.6%
FY24−68.3%−47%
FY23−40.3%−58%
FY22−67.6%−80.4%
FY21−66.5%−71.8%
FY20−86.8%−62.2%
FY19−55.6%−46.2%
FY18-−49.6%